Impax Asset Management Group’s Prestige Consumer Healthcare PBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-65,000
Closed -$3.85M 289
2026
Q1
$3.85M Sell
65,000
-65,000
-50% -$4.22M 0.03% 223
2025
Q4
$8.02M Buy
130,000
+20,000
+18% +$1.22M 0.05% 169
2025
Q3
$6.86M Hold
110,000
0.04% 169
2025
Q2
$8.78M Sell
110,000
-25,000
-19% -$2.09M 0.05% 152
2025
Q1
$11.6M Hold
135,000
0.07% 133
2024
Q4
$10.5M Sell
135,000
-35,000
-21% -$2.72M 0.05% 157
2024
Q3
$12.3M Hold
170,000
0.05% 146
2024
Q2
$11.7M Hold
170,000
0.05% 149
2024
Q1
$12.3M Hold
170,000
0.05% 152
2023
Q4
$10.4M Hold
170,000
0.04% 172
2023
Q3
$9.72M Hold
170,000
0.04% 162
2023
Q2
$10.1M Hold
170,000
0.04% 158
2023
Q1
$10.6M Hold
170,000
0.04% 153
2022
Q4
$10.6M Buy
170,000
+50,000
+42% +$2.87M 0.05% 154
2022
Q3
$5.98M Buy
+120,000
New +$6.64M 0.03% 181

Other funds holding PBH

Impax Asset Management Group's PBH Position: Q2 2026 in Review

Impax Asset Management Group sold out of Prestige Consumer Healthcare (PBH) in Q2 2026, closing a stake of 65,000 shares — an estimated $3.85M sold.

Impax Asset Management Group first reported a position in PBH in Q3 2022 and held it in 15 quarters. The position peaked at $12.3M in Q1 2024. 318 funds tracked by Wall St. Rank hold PBH as of Q2 2026.

  • Impax Asset Management Group reported no remaining Prestige Consumer Healthcare position as of Q2 2026 after selling out during the quarter.
  • Impax Asset Management Group sold 65,000 Prestige Consumer Healthcare shares in Q2 2026, an estimated $3.85M.
  • Impax Asset Management Group first reported a position in Prestige Consumer Healthcare in Q3 2022 and held it in 15 quarters.
  • Impax Asset Management Group's Prestige Consumer Healthcare position peaked at $12.3M in Q1 2024.
  • 318 funds tracked by Wall St. Rank held Prestige Consumer Healthcare as of Q2 2026.

Based on Impax Asset Management Group's 13F filing for Q2 2026, filed 11 Aug 2026.